DIPHARMA AND LOGIXX PHARMA ANNOUNCE GRANTING OF MARKETING AUTHORISATION APPROVAL FOR GENERIC SAPROPTERIN IN UNITED KINGDOM
DIPHARMA AND LOGIXX PHARMA ANNOUNCE GRANTING OF MARKETING AUTHORISATION APPROVAL FOR GENERIC SAPROPTERIN IN UNITED KINGDOM
United Kingdom General United Kingdom European Union Kuvan Gaucher Disease Hereditary Tyrosinemia Type Urea Cycle Disorders
Source: pharmiweb.com